Annual report pursuant to Section 13 and 15(d)

LIQUIDITY (Details)

v3.22.2.2
LIQUIDITY (Details) - USD ($)
$ in Thousands, shares in Millions
 1 Months Ended 12 Months Ended
May 04, 2022
May 01, 2022
Jul. 31, 2022
Jan. 31, 2022
Dec. 31, 2020
Jun. 30, 2022
Jun. 30, 2021
Net loss           $ (41,060) $ (20,902)
Net cash used in operating activities           (39,616) (20,441)
Accumulated deficit           (209,198) (168,138)
Cash and cash equivalents           150,410 41,047
Current liabilities           2,462 $ 1,968
Class B Warrants              
Proceeds from warrants issued           39,094  
Registered Direct Offering 2022              
Proceeds from issuances of common stock           64,390  
Gross proceeds from sale of equity $ 110,500            
Remainder of unrestricted equity securities $ 71,400            
Issuance of common stock for cash   $ 117,600       64,390  
Gross proceeds from issuance of common stock for cash (in shares) 3.2 18.0          
Underwriting discounts and commissions expense $ 7,100            
Registered Direct Offering 2022 | Class B Warrants              
Warrants issued 10.9            
Proceeds from warrants issued $ 39,100            
July 2022 Financing | Subsequent event.              
Proceeds from issuances of common stock     $ 12,300        
Gross proceeds from issuance of common stock for cash (in shares)     3.2        
Underwriting discounts and commissions expense     $ 800        
XOMA (US) LLC [Member] | Phase 2 Clinical Trial RZ358 | Xoma License Agreement [Member]              
Milestone closing payment       $ 2,000      
XOMA (US) LLC [Member] | Phase 3 Clinical Trial Rz 358 | Xoma License Agreement [Member] | Plan              
Milestone closing payment       $ 5,000   5,000  
ActiveSite Pharmaceuticals, Inc | Development And License Agreement [Member]              
Milestone closing payment         $ 1,000    
ActiveSite Pharmaceuticals, Inc | Phase 2 Clinical Trial RZ402 | Development And License Agreement [Member] | Plan              
Milestone closing payment           $ 3,000